CVR 45848310Private limited company (ApS)Speciallægers aktiviteter (862200)AalborgFounded 1 Sep 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Speciallægeselskabet Pascal Bonvin ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
2
CVR registry, Aug 2026
Gross profit
2.8M
DKK, annual report 2025
Result
-154.2K
DKK, annual report 2025
Equity
29.9M
DKK, annual report 2025
Pascal Antoine Bonvin50% to under 66.7% of capital, 100% of votes, since 1 Sep 2025
Katja Valérie Bonvin15% to under 20% of capital, since 30 Sep 2025
and 2 morePascal Antoine Bonvinsince 1 Sep 2025
50% to under 66.7% of capital, 100% of votesclass A,Bnotified 30 Sep 2025since 1 Sep 2025
15% to under 20% of capitalclass Bsince 30 Sep 2025
15% to under 20% of capitalclass Bsince 30 Sep 2025
15% to under 20% of capitalclass Bsince 30 Sep 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
2 Danish companies, which own 1 more one level down.
CVR 3215709215% to under 20% of capital and votes
CVR 33502621100% of capital and votes
CVR 3160096010% to under 15% of capital and votes
Found by searching the CVR owner register (ejerregister) for Speciallægeselskabet Pascal Bonvin ApS as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 28663277100% of capital and votes1 Sep 2025 to 5 Sep 2025
Aug 2026, monthly: 2 employees, 2 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| FTE | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Series | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's own headcount as CVR records it, not the annual report's average, which may cover a group. Monthly Dec 2025 to Aug 2026.
Latest Aug 2026, published 21 Oct 2026. Source: CVR employment series (Årsbeskæftigelse, Kvartalsbeskæftigelse, Månedsbeskæftigelse).
| Metric | 2025 |
|---|---|
| Gross profit | 2,782 |
| Operating profit | +846 |
| Result for the year | -154 |
| Equity | 29,880 |
| Total assets | 33,163 |
| Employees (average) | 1 |
| Credit metrics (Dandex calculations) | |
| EBITDA | 1,032 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) | 37.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -14,708 |
| Gearing, NIBD / EBITDA | Net cash |
| ROIC (afkast af investeret kapital) | 5% |
| Capex (investeringer i anlægsaktiver) | 662note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
8 Jan 2025 to 31 Dec 2025, published 3 Jul 2026
Each registered value from the day it took effect, newest first.
Merger (Fusion), as the continuing company (Fortsættende selskab)
Demerger (Spaltning), as the receiving company (Modtagende selskab)
From CVR, read 9 Nov 2026. Text such as the signing rule and purpose is shown as registered.
3 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Vedtægter ændret: 10.09.2025
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en fusionsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende selskaber må antages at være tilstrækkeligt sikrede efter fusionen.
Virksomheden er fusioneret med CVR-nummer: 28663277 SPECIALLÆGESELSKABET PASCAL BONVIN ApS, der samtidigt er opløst.
Vedtægter ændret: 05.09.2025
Nyt navn: Speciallægeselskabet Pascal Bonvin ApS
Formål ændret: Selskabets formål er at drive speciallægevirksomhed indenfor øre, næse og hals og virksomhed, der er naturligt forbundet hermed.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående spaltning. Kapitalejerne har i enighed besluttet, at der ikke skal udarbejdes en spaltningsplan. Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i de deltagende virksomheder må antages at være tilstrækkeligt sikrede efter spaltningen.
Virksomheden er d. 01.09.2025 opstået efter spaltning. Aktiver og gæld er overdraget fra CVR-nummer: 45221334 Speciallægeselskabet Pascal Bonvin Holding ApS, der samtidigt er opløst.
Seneste vedtægtsdato: 01.09.2025.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt ved spaltning kr. 40.000,00 til kurs 75.084,66, fuldt indbetalt.
Direktion:
Pascal Antoine Bonvin, den 01.09.2025.
Selskabet tegnes af direktionen.
Revision:
CVR-NR. 29442789 REDMARK, GODKENDT REVISIONSPARTNERSELSKAB, Hasseris Bymidte 6, 9000 Aalborg, den 01.09.2025.
Første regnskabsår:
08.01.2025 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at eje kapitalandele i et speciallægeselskab.
1 registered in CVR.
P-number 1031627911Poppelvej 22, 9000 Aalborg
No other current company drawn.
No other current company drawn.
No other current company drawn.